BPC-157

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. These products are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. Purchasers must be 21 years or older. By purchasing, the buyer agrees to use these products in compliance with all applicable laws and regulations.

BPC-157 Overview

BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, originally derived from a naturally occurring protein fragment identified in gastric tissue. Since its description in the early 1990s, BPC-157 has been studied extensively in controlled experimental settings for its potential influence on molecular signaling, structural remodeling, and angiogenic processes.

History

The peptide was first characterized by researchers investigating cytoprotective proteins found in gastric juice. Early experiments focused on its ability to support structural integrity in gastric models. Over time, studies broadened into structural, vascular, and epithelial systems, where BPC-157 has been reported to show properties of interest in the context of molecular remodeling and biological resilience in preclinical models.

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: 4813.45 g/mol

Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.5 g/mol

Research Findings

BPC-157 has been studied in structural, vascular, epithelial, and systemic models, with reports of activity in collagen regulation, extracellular matrix remodeling, angiogenesis, and cell migration. Research also highlights signaling roles in preclinical systems.

Key Areas of Research:

• Structural: Collagen, matrix, tendon
• Vascular: Angiogenesis, nitric oxide signaling
• Epithelial: Migration, vessel formation, matrix
• Systemic: Signaling, viability, pathway dynamics

Together, these findings suggest broad experimental utility for BPC-157 across multiple biological pathways. By influencing processes such as collagen regulation, vascular formation, and molecular signaling, it provides a versatile platform for research into pathway dynamics and systemic resilience within experimental settings.

References

Sikirić, P., et al. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of Physiology (Paris), 87(5), 313–327.

Jelovac, N., Sikiric, P., et al. (1999). Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics. European Journal of Pharmacology, 379(1), 19–31.

Staresinic, M., et al. (2003). Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocyte growth. Journal of Orthopaedic Research, 21(6), 976–983.

Sikiric, P., Seiwerth, S., Brcic, L., et al. (2006). Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. Inflammopharmacology, 14(5–6), 214–221.

Chang, C.H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774–780.

Sikiric, P., et al. (2011). Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 17(16), 1612–1632.